2016-03-15T00:00:00.000-04:00
price objective,0.638964
stage biopharmaceutical company,0.263883
Asset Management LLC,0.297727
quarterly earnings results,-0.245004
psychiatric disorders,-0.665652
Arrowpoint Asset Management,0.363563
consensus price target,0.34485
stock,0.329636
Thursday,-0.290563
hold rating,0.0624565
InvestorPlace Broker Center,0.555736
high fees,-0.735674
biopharmaceutical company,0.283517
outperform rating,0.58718
DAFNA Capital Management,0.24274
Marinus Pharmaceuticals,-0.221696
personal trading style,0.598412
average rating,0.34485
Emerald Advisers,0.285163
Capital Management LLC,0.24274
buy rating,0.246739
research note,0.478136
stage product candidate,0.204149
Stifel Nicolaus,0.479498
average price,0.45936
shares,0.320211
focal onset seizures,-0.490035
EverPoint Asset Management,0.23189
stock broker,0.245696
AnalystRatings.Net reports,-0.349012
clinical trial,-0.490035
clinical stage,0.243972
research analyst,0.333228
new position,0.23189
quarter,0.279398
